Literature DB >> 29496057

Effect of adjuvant radiotherapy treatment center volume on overall survival.

Ramez Philips1, Daniel Martin1, Antoine Eskander2, Jeffrey Schord1, Nicole Brown3, Songzhu Zhao3, Guy Brock3, Bhavna Kumar2, Ricardo Carrau2, Enver Ozer2, Amit Agrawal2, Stephen Y Kang2, James W Rocco2, David Schuller2, Syed Ali1, Dukagjin Blakaj4, Aashish Bhatt4, John Grecula4, Theodoros Teknos2, Virginia Diavolitsis4, Matthew Old5.   

Abstract

OBJECTIVES: to examine the impact of radiotherapy center volume on overall survival in patients with oral cavity and oropharyngeal squamous cell carcinoma getting adjuvant radiation therapy after receiving surgery at a high-volume center.
MATERIALS AND METHODS: a retrospective study was conducted on patients with oral cavity squamous cell carcinoma or oropharyngeal squamous cell carcinoma treated surgically at a tertiary institution from 2000 to 2012 who received adjuvant radiotherapy. The outcome variable was overall survival and the independent variable was location of adjuvant radiation therapy: high-volume center (HVC) versus low-volume center (LVC). Cox proportional hazards models were used to assess associations between predictors of death. Variables that were found to be significant at the α = 0.10 were included in a multivariable model.
RESULTS: 336 patients met inclusion criteria. One-hundred thirty-nine patients received adjuvant radiation therapy at HVC and 197 patients received adjuvant radiation therapy at LVC. A univariate Cox proportional hazards model identified the variables location, age, marital status, subsite, T stage, extracapsular extension, and smoking status to include in a multivariable model. Age, subsite, T stage, and extracapsular extension were independent predictors of overall survival (p < .05). Location (p = .55), marital status (p = .29), and smoking status (p = .22) were not statistically significant predictors of survival.
CONCLUSION: After surgery at a HVC, the volume of adjuvant radiation therapy center was not significantly associated with overall survival. Significant predictors of survival included age, subsite, T stage, and extracapsular extension.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant therapy; Head and neck cancer; Healthcare outcomes; Institution volume; Oral cavity cancer; Oropharyngeal cancer; Overall survival; Physician volume; Radiation therapy

Mesh:

Year:  2018        PMID: 29496057      PMCID: PMC7237051          DOI: 10.1016/j.oraloncology.2018.01.004

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  15 in total

1.  Adherence to guideline-recommended process measures for squamous cell carcinoma of the head and neck in Ontario: Impact of surgeon and hospital volume.

Authors:  Antoine Eskander; Eric Monteiro; Jonathan Irish; Patrick Gullane; Ralph Gilbert; John de Almeida; Dale Brown; Jeremy Freeman; David R Urbach; David P Goldstein
Journal:  Head Neck       Date:  2016-02-01       Impact factor: 3.147

Review 2.  Provider volume and outcomes for oncological procedures.

Authors:  S D Killeen; M J O'Sullivan; J C Coffey; W O Kirwan; H P Redmond
Journal:  Br J Surg       Date:  2005-04       Impact factor: 6.939

3.  High case volume of radiation oncologists is associated with better survival of nasopharyngeal carcinoma patients treated with radiotherapy: a multifactorial cohort analysis.

Authors:  C-R Chien; H-W Lin; C-H Yang; S-N Yang; Y-C Wang; Y-C Kuo; S-W Chen; J-A Liang
Journal:  Clin Otolaryngol       Date:  2011-12       Impact factor: 2.597

4.  Travelling all over the countryside: travel-related burden and financial difficulties reported by cancer patients in New South Wales and Victoria.

Authors:  Alison Zucca; Allison Boyes; Graham Newling; Alix Hall; Afaf Girgis
Journal:  Aust J Rural Health       Date:  2011-12       Impact factor: 1.662

5.  Close, but still too far. The experience of Australian people with cancer commuting from a regional to a capital city for radiotherapy treatment.

Authors:  D Hegney; S Pearce; C Rogers-Clark; K Martin-McDonald; E Buikstra
Journal:  Eur J Cancer Care (Engl)       Date:  2005-03       Impact factor: 2.520

6.  Institutional clinical trial accrual volume and survival of patients with head and neck cancer.

Authors:  Evan J Wuthrick; Qiang Zhang; Mitchell Machtay; David I Rosenthal; Phuc Felix Nguyen-Tan; André Fortin; Craig L Silverman; Adam Raben; Harold E Kim; Eric M Horwitz; Nancy E Read; Jonathan Harris; Qian Wu; Quynh-Thu Le; Maura L Gillison
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

7.  The effect of an intensive nutritional program on daily set-up variations and radiotherapy planning margins of head and neck cancer patients.

Authors:  A Mercuri; D Lim Joon; M Wada; A Rolfo; V Khoo
Journal:  J Med Imaging Radiat Oncol       Date:  2009-10       Impact factor: 1.735

8.  Impact of hospital volume on operative mortality for major cancer surgery.

Authors:  C B Begg; L D Cramer; W J Hoskins; M F Brennan
Journal:  JAMA       Date:  1998-11-25       Impact factor: 56.272

9.  Comparison of Failure Patterns Between Conventional and Intensity-modulated Radiotherapy for Stage III and IV Head and Neck Squamous Cell Carcinoma.

Authors:  Jin Ho Song; Bae-Kwon Jeong; Hoon-Sik Choi; Hojin Jeong; Myoung Hee Kang; Jung Hun Kang; Jin Pyeong Kim; Jung Je Park; Seung Hoon Woo; Hong Seok Jang; Byung Ock Choi; Ki Mun Kang
Journal:  Anticancer Res       Date:  2015-12       Impact factor: 2.480

10.  Survival rate in nasopharyngeal carcinoma improved by high caseload volume: a nationwide population-based study in Taiwan.

Authors:  Ching-Chih Lee; Tze-Ta Huang; Moon-Sing Lee; Yu-Chieh Su; Pesus Chou; Shih-Hsuan Hsiao; Wen-Yen Chiou; Hon-Yi Lin; Sou-Hsin Chien; Shih-Kai Hung
Journal:  Radiat Oncol       Date:  2011-08-11       Impact factor: 3.481

View more
  2 in total

1.  Radiation therapy treatment facility and overall survival in the adjuvant setting for locally advanced head and neck squamous cell carcinoma.

Authors:  Nicholas C J Lee; Jacqueline R Kelly; Yi An; Henry S Park; Benjamin L Judson; Barbara A Burtness; Zain A Husain
Journal:  Cancer       Date:  2019-02-12       Impact factor: 6.860

2.  Genipin Induces Autophagy and Suppresses Cell Growth of Oral Squamous Cell Carcinoma via PI3K/AKT/MTOR Pathway.

Authors:  MingBo Wei; YanLi Wu; Hui Liu; Chun Xie
Journal:  Drug Des Devel Ther       Date:  2020-01-29       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.